Literature DB >> 8588121

Autoreactivity to mouse C1q in a murine model of SLE.

P K Trinder1, M J Maeurer, H U Schorlemmer, M Loos.   

Abstract

A large proportion of systemic lupus erythematosus (SLE) patients develop glomerulonephritis, coincident with the appearance of autoantibodies to C1q, the Fc-recognizing collagen-like subcomponent of the first component of complement, C1. The MRL/lpr/lpr mouse is an established model for SLE, developing both antinuclear and anti-type II collagen autoantibodies, and rheumatoid factors(s), exhibiting reduced complement levels and later on developing glomerulonephritis and often arthritis. We report here an age-dependent decrease in serum C1q levels coincident with the development of IgG2b autoantibodies reactive with mouse C1q in MRL/lpr/lpr mice. Unlike IgG2b, although high levels of IgM, IgG1 and IgG2a are present in these mice, few, if any, antibodies of these subclasses reactive with mouse C1q were observed in this study. This is the first report of autoantibodies against autologous C1q in an animal model, and the results should facilitate in clarification of the roles of C1q and autoantibodies reactive with C1q in SLE, as well as their potential connection with glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588121     DOI: 10.1007/bf00302128

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

Review 1.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

Review 2.  Autoantibodies against C1q in systemic lupus erythematosus.

Authors:  C E Siegert; F C Breedveld; M R Daha
Journal:  Behring Inst Mitt       Date:  1993-12

3.  Purification and characterization of human, guinea pig and mouse C1q by fast protein liquid chromatography (FPLC).

Authors:  F Stemmer; M Loos
Journal:  J Immunol Methods       Date:  1984-11-16       Impact factor: 2.303

4.  Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice.

Authors:  J H Slack; L Hang; J Barkley; R J Fulton; L D'Hoostelaere; A Robinson; F J Dixon
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

5.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

6.  Gene expression of the A- and B-chain of mouse C1q in different tissues and the characterization of the recombinant A-chain.

Authors:  F Petry; K B Reid; M Loos
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

7.  Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.

Authors:  U Antes; H P Heinz; M Loos
Journal:  Arthritis Rheum       Date:  1988-04

8.  The mechanism of autoantibody production in an autoimmune MRL/lpr mouse.

Authors:  H Shan; M J Shlomchik; A Marshak-Rothstein; D S Pisetsky; S Litwin; M G Weigert
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

9.  Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  A D Cook; M J Rowley; B D Wines; I R Mackay
Journal:  J Autoimmun       Date:  1994-06       Impact factor: 7.094

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  6 in total

1.  Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies.

Authors:  M R Ito; S Terasaki; E Kondo; H Shiwaku; Y Fukuoka; M Nose
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Anti-C1q autoantibodies in murine lupus nephritis.

Authors:  L A Trouw; M A Seelen; R Visseren; J M G J Duijs; H Benediktsson; E de Heer; A Roos; C van Kooten; M R Daha
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

3.  Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

Authors:  Leendert A Trouw; Tom W L Groeneveld; Marc A Seelen; Jacques M G J Duijs; Ingeborg M Bajema; Frans A Prins; Uday Kishore; David J Salant; J Sjef Verbeek; Cees van Kooten; Mohamed R Daha
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

4.  The Pathogenesis of Lupus Nephritis.

Authors:  Rosalie M Sterner; Stella P Hartono; Joseph P Grande
Journal:  J Clin Cell Immunol       Date:  2014-04

Review 5.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09

6.  Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.

Authors:  Kinga Csorba; Lucia A Schirmbeck; Eylul Tuncer; Camillo Ribi; Pascale Roux-Lombard; Carlo Chizzolini; Uyen Huynh-Do; Dominique Vanhecke; Marten Trendelenburg
Journal:  Front Immunol       Date:  2019-11-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.